Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 4/10/20121 min de lectura
New Animal Drugs; Change of Sponsor's Address; Monensin; Spinosad; Tilmicosin
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) during August 2012 and to reflect a change of sponsor's address for Baxter Healthcare Corp. FDA is also informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →